Q2 2025 Aster DM Healthcare Ltd Earnings Call Transcript
Key Points
- Aster DM Healthcare Ltd (BOM:540975) reported robust growth in the Indian healthcare sector, driven by rising healthcare demand and increased government focus on infrastructure.
- The company achieved a 23% CAGR in revenue and a 38% CAGR in operating EBITDA over the last five years in India.
- Aster DM Healthcare Ltd (BOM:540975) recorded an 18% revenue growth in H1 FY25, with a significant increase in operating EBITDA margins from 16.1% to 19.6%.
- The company is expanding its capacity with plans to add approximately 1,800 beds by FY27, enhancing its ability to meet growing healthcare demands.
- Aster DM Healthcare Ltd (BOM:540975) is making significant progress in oncology services, introducing advanced cancer care technologies like interoperative electron radiation therapy.
- The company faces risks and uncertainties related to government actions, local political or economic developments, and technological risks.
- Despite strong performance, there is a potential risk of not meeting demand due to high occupancy rates and limited immediate bed expansion.
- The wholesale pharmacy segment has been restructured due to logistical challenges, impacting revenue but reducing EBITDA losses.
- The company has seen senior-level attrition in Kerala and Karnataka, though it claims this is not impacting performance.
- Aster DM Healthcare Ltd (BOM:540975) has a high level of pledged shares due to technical reasons, which it plans to address by the end of the year.
Good morning everyone. I welcome you to Aster DM Healthcare earnings conference call for the second quarter of FY25. The company declared the Q2 results for a 525.
With us. We have the Senior management of Aster DM Healthcare namely Ms. Alisha Moopen, Deputy Managing Director; Mr. TJ Wilson, Non-Executive Director; Mr. Anoop Moopen, Non-Executive Director; Mr. Ramesh Kumar, Chief Operating Officer; Mr Sunil Kumar, Chief Financial Officer; and Mr Hitesh Dhaddha, Chief of Investor relations and Mergers and Acquisitions. (Operator Instructions)
We will start the call with opening remarks by management followed by an interactive Q&A session. (Operator Instructions)
We request you to please limit your question to two but not more than three per participant at a time, certain forward-looking statements may be discussed in this meeting and such statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks and many other factors that could cause actual results to differ. Materially.
Adium
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
